Shares of Henry Schein Inc. HSIC slipped 4.09% to $69.94 Wednesday, on what proved to be an all-around mixed trading session ...

The stock's rise snapped a three-day losing streak.

Dental and medical products company Henry Schein (NASDAQ:HSIC) in Q4 CY2024, but sales rose 5.8% year on year to $3.19 billion. Its non-GAAP profit of $1.19 per share was 1.6% below analysts’ ...

Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eleven analysts that are currently covering the firm, Marketbeat.com reports.

The firm purchased 501,734 shares of the company’s stock, valued at approximately $34,720,000. Raymond James Financial Inc. owned about 0.40% of Henry Schein as of its most recent filing with ...

Henry Schein's market leadership and strategic acquisitions across various healthcare segments make it a solid investment, ...

Henry Schein has been outperforming the S&P 500 since December 2024. Check out the price action, momentum, volume, and ...

Investors and stakeholders in Henry Schein Inc. will likely watch for further announcements to understand the implications of this executive shift. The company’s stock performance and market ...

HENRY SCHEIN ($HSIC) posted quarterly earnings results on Tuesday, February 25th. The company reported earnings of $1.19 per share, missing estimates of $1.24 by $0. ...

HENRY SCHEIN ($HSIC) is expected to release its quarterly earnings data on Tuesday, February 25th before market open, per Finnhub. Analysts are expecting revenue of ...